Cite
HARVARD Citation
Staudacher, D. et al. (2019). Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. European heart journal. 8 (6), pp. 520-526. [Online].